Cita APA

Scott, F. I., Luo, M., Shah, Y., Lasch, K., Vajravelu, R. K., Mamtani, R., . . . Lewis, J. D. (2020). Identification of the Most Cost-effective Position of Vedolizumab Among the Available Biologic Drugs for the Treatment of Ulcerative Colitis. J Crohns Colitis.

Chicago Style Citation

Scott, Frank I., Michelle Luo, Yash Shah, Karen Lasch, Ravy K. Vajravelu, Ronac Mamtani, Blair Fennimore, Mark E. Gerich, i James D. Lewis. "Identification of the Most Cost-effective Position of Vedolizumab Among the Available Biologic Drugs for the Treatment of Ulcerative Colitis." J Crohns Colitis 2020.

Cita MLA

Scott, Frank I., et al. "Identification of the Most Cost-effective Position of Vedolizumab Among the Available Biologic Drugs for the Treatment of Ulcerative Colitis." J Crohns Colitis 2020.